An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples.

MET NSCLC molecular test

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
08 Feb 2023
Historique:
received: 11 11 2022
revised: 24 01 2023
accepted: 03 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 26 2 2023
Statut: epublish

Résumé

Lung cancer remains the leading cause of cancer deaths worldwide. International societies have promoted the molecular analysis of MET proto-oncogene, receptor tyrosine kinase (

Identifiants

pubmed: 36832117
pii: diagnostics13040629
doi: 10.3390/diagnostics13040629
pmc: PMC9955861
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Thorac Oncol. 2018 Dec;13(12):1873-1883
pubmed: 30195702
J Clin Oncol. 2016 Mar 10;34(8):794-802
pubmed: 26215952
J Natl Cancer Inst. 2017 May 1;109(5):
pubmed: 28376232
Curr Oncol Rep. 2020 Apr 16;22(5):48
pubmed: 32296961
Biomark Res. 2022 Mar 7;10(1):9
pubmed: 35255999
J Clin Pathol. 2023 Jan;76(1):47-52
pubmed: 34429353
Lancet Respir Med. 2021 Oct;9(10):1154-1164
pubmed: 34166627
Diagnostics (Basel). 2019 Jan 18;9(1):
pubmed: 30669306
Cancers (Basel). 2022 Apr 30;14(9):
pubmed: 35565387
J Thorac Oncol. 2019 Jul;14(7):1134-1155
pubmed: 31002952
J Thorac Oncol. 2017 Oct;12(10):1582-1587
pubmed: 28779874
JCO Precis Oncol. 2021 Apr 13;5:
pubmed: 34036238
Clin Cancer Res. 2019 Aug 1;25(15):4712-4722
pubmed: 31028088
Cytopathology. 2021 Sep;32(5):588-595
pubmed: 33792981
Lung Cancer (Auckl). 2021 May 20;12:35-50
pubmed: 34295201
J Thorac Oncol. 2019 Apr;14(4):737-741
pubmed: 30639620
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Lung Cancer. 2017 Apr;106:131-137
pubmed: 28285687
N Engl J Med. 2020 Sep 3;383(10):931-943
pubmed: 32469185
Signal Transduct Target Ther. 2019 Dec 17;4:61
pubmed: 31871778
Expert Opin Investig Drugs. 2020 Apr;29(4):363-372
pubmed: 32073317
N Engl J Med. 2020 Sep 3;383(10):944-957
pubmed: 32877583
Lung Cancer. 2017 Jan;103:27-37
pubmed: 28024693
J Clin Oncol. 2016 Mar 1;34(7):721-30
pubmed: 26729443
Transl Lung Cancer Res. 2022 May;11(5):711-721
pubmed: 35693289
Cancer Discov. 2015 Aug;5(8):850-9
pubmed: 25971938
Clin Lung Cancer. 2019 Jan;20(1):e123-e132
pubmed: 30391211
Cancer Discov. 2015 Aug;5(8):842-9
pubmed: 25971939
Cancer Cytopathol. 2019 May;127(5):285-296
pubmed: 31021538
Cancer Cytopathol. 2017 Aug;125(8):615-626
pubmed: 28475299

Auteurs

Paolo Bironzo (P)

Department of Oncology, S. Luigi Gonzaga Hospital, University of Turin, 10043 Orbassano, Italy.

Francesco Pepe (F)

Department of Public Health, University Federico II of Naples, 80131 Naples, Italy.

Gianluca Russo (G)

Department of Public Health, University Federico II of Naples, 80131 Naples, Italy.

Pasquale Pisapia (P)

Department of Public Health, University Federico II of Naples, 80131 Naples, Italy.

Gianluca Gragnano (G)

Department of Public Health, University Federico II of Naples, 80131 Naples, Italy.

Gabriella Aquino (G)

Department of Pulmonary Oncology, AORN Dei Colli Monaldi, 80131 Naples, Italy.

Silvia Bessi (S)

Departmental Structure of Oncological Molecular Pathology, Oncological Department Azienda USL Toscana Centro, S. Stefano Hospital, 59100 Prato, Italy.

Simonetta Buglioni (S)

Pathology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Federico Bartoccini (F)

Pathology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Giuseppina Ferrero (G)

Department of Pathology, ASST Cremona, 26100 Cremona, Italy.

Michela Anna Bresciani (MA)

Department of Pathology, ASST Cremona, 26100 Cremona, Italy.

Paola Francia di Celle (P)

Molecular Pathology, AOU Città della Salute e della Scienza di Torino-Presidio Ospedaliero Molinette, 10126 Turin, Italy.

Francesca Sibona (F)

Molecular Pathology, AOU Città della Salute e della Scienza di Torino-Presidio Ospedaliero Molinette, 10126 Turin, Italy.

Andrea Giusti (A)

ASL Toscana Nord Ovest, Pathology Unit, Centro Polispecialistico "Achille Sicari", 54033 Carrara, Italy.

Alessandra Movilia (A)

Department of Pathology, ASST Ovest Milanese, Ospedale di Legnano, 20025 Legnano, Italy.

Renata Mariella Farioli (RM)

Department of Pathology, ASST Ovest Milanese, Ospedale di Legnano, 20025 Legnano, Italy.

Alessandra Santoro (A)

Division of Hematology and Bone Marrow Transplantation, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy.

Domenico Salemi (D)

Division of Hematology and Bone Marrow Transplantation, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy.

Stefania Scarpino (S)

Pathology Unit, Department of Clinical and Molecular Medicine, St. Andrea University Hospital, University of Rome La Sapienza, 00189 Rome, Italy.

Dino Galafate (D)

Pathology Unit, Department of Clinical and Molecular Medicine, St. Andrea University Hospital, University of Rome La Sapienza, 00189 Rome, Italy.

Stefania Tommasi (S)

Molecular Genetics Laboratory, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.

Rosanna Lacalamita (R)

Molecular Genetics Laboratory, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.

Davide Seminati (D)

Department of Surgery and Translational Medicine, Section of Pathology, Università degli Studi di Mila-no-Bicocca, 20126 Milan, Italy.

Elham Sajjadi (E)

Department of Oncology and Hemato-Oncology, University of Milan, 20136 Milan, Italy.

Silvia Novello (S)

Department of Oncology, S. Luigi Gonzaga Hospital, University of Turin, 10043 Orbassano, Italy.

Fabio Pagni (F)

Department of Surgery and Translational Medicine, Section of Pathology, Università degli Studi di Mila-no-Bicocca, 20126 Milan, Italy.

Giancarlo Troncone (G)

Department of Public Health, University Federico II of Naples, 80131 Naples, Italy.

Umberto Malapelle (U)

Department of Public Health, University Federico II of Naples, 80131 Naples, Italy.

Classifications MeSH